spacer
home > pmps > spring 2007 > entering the mainstream
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Entering the Mainstream

Larry Klimczyk of Blackbay addresses the need to encourage widespread adoption of RFID in the pharmaceutical industry

In 2006 there was considerable hype surrounding Pfizer’s intent to employ RFID in Viagra packaging. Now, in 2007, many others within the pharmaceutical industry are also poised to begin reaping the benefits of RFID. RFID has the potential to offer much more than the established technologies such as barcoding to the pharmaceutical industry. Although RFID promises significant bottom line benefits, take-up has been slower than predicted. New developments are leading to more widespread adoption, but it is still considered by many to lack the plug and play maturity that so many businesses have come to expect from their technology tools.

PROVEN BENEFITS

Although the comparative advantages of RFID over the barcode have been stated, barcoding’s chief advantage still stands: it is incredibly cheap to produce. However, RFID’s benefits are many and impressive: non-line-of-sight reading; the ability to read multiple tags at once; the ability to store information on the back of a tag; the ability to consolidate a lot of information in a very small physical space; the ability to combine this information with telemetry information, such as temperature; and the ability to read at distance. These are making some headway towards creating cost effective solutions for enterprise. Some of the key benefits projected for the pharmaceutical industry in particular are:

  • The ability to identify drugs at the individual and container level
  • Assurance that the ID on the bottle has not been forged or mislabelled
  • Minimised line-of-sight requirements to read product information
  • Remote tracking of product movement and location
  • Increased potential for reducing clinical trial times by reducing errors and improving delivery accuracy

There has been much speculation over the advantages of adopting RFID. In fact, many early adopters claim that they are already seeing a return on their investment. RFID can address many specific engineering and technical issues, but there is no one-size-fits-all answer and all but the simplest solutions will require specific engineering.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Larry Klimczyk, Managing Director of Blackbay, has over 20 years of management experience with Symbol Technologies, Deutsche Post and TPG. Larry has accumulated a wealth of knowledge in international distribution, creating technology solutions in data capture, mobile computing and wireless communication. An experienced speaker at international conferences, his work has supported a wide range of industries in maximising their return on investment, improving business processes for data capture and communication in real-time. To complement his hands-on international experience, Larry also has an MBA in Asia Pacific studies with the National University of Singapore.
spacer
Larry Klimczyk
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sphere Fluidics Closes a $4.8 million USD (£3.7 million) Funding Round

Cambridge, UK, 10 June 2019: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has closed an additional tranche of investment of $2.9 million (£2.2 million), securing a total of $4.8 million (£3.7 million) in investment. The funding will be used as working capital for the Company’s Cyto-Mine® Single Cell Analysis System, expansion of the UK facility and enable the doubling of personnel through the opening of a new US Sales Office and Demo Lab in California.
More info >>

White Papers

Generating Scientific Insights by Deep Collaboration - Bridging the Big Data Divide Between Clinical and Research

BioFortis

Translational research, biomarker discovery, clinical studies and even biobanking have become increasingly data intensive.  However, generating scientific insights from such disparate “big” data sources across multiple domains is a challenge for both researchers and the informaticians that support them. Download our Deep Collaboration Whitepaper and and learn how to bridge the clinical and research divide to better explore your biomarker based trials.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement